Morgan Stanley Tyra Biosciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 68,916 shares of TYRA stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,916

Previous 64,531 6.8%

Holding current value

$1.09 Million

Previous $1.03 Million 57.13%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.7 - $24.36 $73,229 - $106,818	4,385 Added 6.8%	68,916 $1.62 Million
Q2 2024 Oct 17, 2024	BUY	$14.45 - $20.22 $423,298 - $592,324	29,294 Added 83.13%	64,531 $1.03 Million
Q2 2024 Aug 14, 2024	BUY	$14.45 - $20.22 $423,298 - $592,324	29,294 Added 83.13%	64,531 $1.03 Million
Q1 2024 Oct 17, 2024	SELL	$11.61 - $20.0 $340,103 - $585,880	-29,294 Reduced 45.4%	35,237 $577,000
Q1 2024 Aug 16, 2024	SELL	$11.61 - $20.0 $5,003 - $8,620	-431 Reduced 1.21%	35,237 $577,000
Q1 2024 May 15, 2024	SELL	$11.61 - $20.0 $5,003 - $8,620	-431 Reduced 1.21%	35,237 $577,000
Q4 2023 Aug 16, 2024	SELL	$11.01 - $14.95 $317,781 - $431,501	-28,863 Reduced 44.73%	35,668 $494,000
Q4 2023 Feb 13, 2024	BUY	$11.01 - $14.95 $191,397 - $259,890	17,384 Added 95.08%	35,668 $494,000
Q3 2023 Nov 15, 2023	SELL	$13.15 - $16.08 $6,390 - $7,814	-486 Reduced 2.59%	18,284 $251,000
Q2 2023 Aug 14, 2023	BUY	$11.99 - $17.51 $41,497 - $60,602	3,461 Added 22.61%	18,770 $319,000
Q1 2023 May 15, 2023	BUY	$6.85 - $16.22 $33,606 - $79,575	4,906 Added 47.16%	15,309 $246,000
Q4 2022 Feb 14, 2023	SELL	$5.68 - $8.81 $12,035 - $18,668	-2,119 Reduced 16.92%	10,403 $79,000
Q3 2022 Nov 14, 2022	SELL	$6.61 - $12.42 $6,041 - $11,351	-914 Reduced 6.8%	12,522 $110,000
Q2 2022 Oct 27, 2022	BUY	$5.26 - $11.19 $62,409 - $132,769	11,865 Added 755.25%	13,436 $96,000
Q2 2022 Aug 15, 2022	BUY	$5.26 - $11.19 $62,409 - $132,769	11,865 Added 755.25%	13,436 $96,000
Q1 2022 Oct 27, 2022	SELL	$10.03 - $14.09 $119,005 - $167,177	-11,865 Reduced 88.31%	1,571 $16,000
Q1 2022 May 13, 2022	SELL	$10.03 - $14.09 $342,795 - $481,553	-34,177 Reduced 95.61%	1,571 $16,000
Q4 2021 Feb 14, 2022	BUY	$12.23 - $31.35 $437,198 - $1.12 Million	35,748 New	35,748 $503,000

Others Institutions Holding TYRA

# of Institutions

Shares Held

43.3M

Call Options Held

353K

Put Options Held

1.1K

View Full List

About Tyra Biosciences, Inc.

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $663M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

More about TYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account